Ustekinumab is used to treat inflammatory types of arthritis, such as psoriatic arthritis (PsA), by blocking inflammatory proteins interleukin-12 and 23 (IL-12, IL-23). It can help suppress an overactive immune system, but can also increase your risk for certain infections. There are biosimilar versions of ustekinumab, which are highly similar versions of the drug which have the. . .
Drug Class: Biologic
Tocilizumab
Tocilizumab is used to treat inflammatory types of arthritis, such as rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). It works by blocking interleukin-6 (IL-6), a protein which is involved in the body’s inflammatory response. Tocilizumab can help suppress an overactive immune system, but can also increase your risk for certain infections.
Secukinumab
Secukinumab is used to treat inflammatory types of arthritis, such as psoriatic arthritis (PsA) and ankylosing spondylitis (AS) by neutralizing interleukin-17 (IL-17), a pro-inflammatory protein. Secukinumab can help suppress an overactive immune system, but can also increase your risk for certain infections.
Sarilumab
Sarilumab is used to treat inflammatory types of arthritis, such as rheumatoid arthritis (RA), by binding to IL-6 and preventing it from causing inflammation. It can help suppress an overactive immune system, but can also increase your risk for certain infections.
Rituximab
Rituximab is used to treat inflammatory types of arthritis, such as rheumatoid arthritis (RA) and granulomatosis with polyangiitis (GPA, also known as Wegener’s Granulomatosis). Rituximab works by stopping B-cells from triggering an immune response against the body’s own tissues. It can help suppress an overactive immune system, but can also increase your risk for certain infections.
Ixekizumab
Ixekizumab is used to treat inflammatory types of arthritis, such as psoriatic arthritis (PsA) and ankylosing spondylitis (AS) by blocking interleukin-17, a molecule that triggers inflammation. It can help suppress an overactive immune system, but can also increase your risk for certain infections.
Infliximab
Infliximab is used to treat inflammatory types of arthritis, such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS). It is also used to treat Crohn’s disease, ulcerative colitis and plaque psoriasis. It can help suppress an overactive immune system, but can also increase your risk for certain infections. There are biosimilar versions of infliximab, which are highly. . .
Guselkumab
Guselkumab is used to treat inflammatory types of arthritis, such as psoriatic arthritis (PsA), by blocking inflammatory protein interleukin-23 (IL-23). It can help suppress an overactive immune system, but can also increase your risk for certain infections.
Golimumab
Golimumab is used to treat inflammatory types of arthritis, such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS). Golimumab treats arthritis by binding to tumour necrosis factor (TNF) and preventing it from causing inflammation. It can help suppress an overactive immune system, but can also increase your risk for certain infections.
